Asian Cancer Foundation Profile
Key Indicators
- Paid Up Capital ₹ 3.91 M
as on 04-07-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 70.48%
(FY 2023)
- Profit 595.09%
(FY 2023)
- Ebitda 10390.42%
(FY 2023)
- Net Worth 11.48%
(FY 2023)
- Total Assets 10.67%
(FY 2023)
About Asian Cancer Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 3.91 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Parikh, Sanjay Sharma, Gopal Ramakrishnan, and One other member serve as directors at the Company.
- CIN/LLPIN
U91120MH2005NPL152302
- Company No.
152302
- Company Classification
Public Not For Profit Company
- Incorporation Date
31 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Asian Cancer Foundation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakant Deshpande  | Director | 31-Mar-2005 | Current |
| Deepak Parikh | Director | 31-Mar-2005 | Current |
| Sanjay Sharma | Director | 28-Nov-2016 | Current |
| Gopal Ramakrishnan | Director | 31-Mar-2005 | Current |
Financial Performance of Asian Cancer Foundation.
Asian Cancer Foundation, for the financial year ended 2023, experienced significant growth in revenue, with a 70.48% increase. The company also saw a substantial improvement in profitability, with a 595.09% increase in profit. The company's net worth Soared by an impressive increase of 11.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asian Cancer Foundation?
Unlock access to Asian Cancer Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Asian Oncology Private LimitedActive 8 years 1 monthSanjay Sharma and Ramakant Deshpande are mutual person
Asian Institute Of Oncology Private LimitedActive 22 years 19 daysSanjay Sharma and Ramakant Deshpande are mutual person
- Triumph Cancer Institute Private LimitedActive 6 years 9 months
Sanjay Sharma and Ramakant Deshpande are mutual person
- Karnataka Leasing And Commercial Corporation LimitedActive 39 years 10 months
Ramakant Deshpande is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asian Cancer Foundation?
Unlock and access historical data on people associated with Asian Cancer Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asian Cancer Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asian Cancer Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
